Blood Restricted Antigen #4

No authoritative evidence supports \"Blood Restricted Antigen #4\" as the canonical name of a known therapeutic target. Searches of major biomedical sources did not return a recognized human protein, receptor, enzyme, transporter, or gene under this exact term, suggesting that the entry is likely malformed or nonstandard. ([scbt.com](https://www.scbt.com/p/cd15-antibody-bra-4f1))\n\nThe available search results instead point to unrelated antigen-testing or antibody-clone terms, such as the antibody clone name \"BRA-4F1\" used for CD15 detection, rather than a target called \"Blood Restricted Antigen #4.\" Because the identity of the molecule is uncertain, no reliable assignment can be made for drug interactions, disease biology, biomarkers, or target class. This entry should be flagged for manual review and corrected using a more standard molecular name, gene symbol, antibody target, or accession identifier before downstream structuring. ([scbt.com](https://www.scbt.com/p/cd15-antibody-bra-4f1))

No reliable evidence was found that \"Blood Restricted Antigen #4\" is a recognized molecular target, receptor, enzyme, transporter, or other therapeutic target in standard biomedical databases or literature. Web searches did not identify a canonical protein, gene, or receptor with this exact name in major sources such as UniProt, NCBI, PubMed, or Wikipedia. The phrase appears likely to be incorrect, misspelled, ambiguous, or confused with a different antigen-related term. ([scbt.com](https://www.scbt.com/p/cd15-antibody-bra-4f1))